Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response.
Hannesdóttir L, Tymoszuk P, Parajuli N, Wasmer MH, Philipp S, Daschil N, Datta S, Koller JB, Tripp CH, Stoitzner P, Müller-Holzner E, Wiegers GJ, Sexl V, Villunger A, Doppler W.
Hannesdóttir L, et al. Among authors: villunger a.
Eur J Immunol. 2013 Oct;43(10):2718-29. doi: 10.1002/eji.201242505. Epub 2013 Jul 11.
Eur J Immunol. 2013.
PMID: 23843024
Free article.